“…Treatment of neonatal rats with the combination of desmethylimipramine (DMI) and 6-hydroxydopamine (6-OHDA) produces a depletion of brain dopamine (DA) and a series of behavioral effects that includes hyperactivity from postnatal day 15 through 30 (Concannon, Braughler, & Schechter, 1983;Erinoff, MacPhail, Heller, & Seiden, 1979;Miller, Heffner, Kotake, & Seiden, 1981;Pappas, Gallivan, Dugas, Saari, & Ings, 1980;Shaywitz, Yager, & Klopper, 1976; Thieme, Dijkstra, & Stoof, 1980) and a decrease in habituation in a novel environment (Shaywitz, Gordon, Klopper, & Zelterman, 1977;Stoof, Dijkstra, & Hillegers, 1978). In addition to alterations in activity levels, rats tested for avoidance and escape learning are impaired in their performance at age 20 days and beyond (Lipton, McGough, & Shaywitz, 1980;Shaywitz, Goldenring, & Wool, 1979; Shaywitz, Klopper, & Gordon, 1978;Shaywitz, Lipton, Teicher, Cohen, Anderson, Batter, & Young, 1981;Smith, Cooper, & Breese, 1973).…”